Brokerages predict that Cantel Medical Corp. (NYSE:CMD) will announce earnings per share of $0.56 for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Cantel Medical’s earnings, with the lowest EPS estimate coming in at $0.55 and the highest estimate coming in at $0.56. Cantel Medical posted earnings of $0.62 per share in the same quarter last year, which indicates a negative year over year growth rate of 9.7%. The firm is expected to issue its next earnings report before the market opens on Tuesday, December 10th.

On average, analysts expect that Cantel Medical will report full-year earnings of $2.81 per share for the current year. For the next year, analysts forecast that the company will post earnings of $3.38 per share, with EPS estimates ranging from $3.34 to $3.41. Zacks’ earnings per share averages are a mean average based on a survey of research analysts that follow Cantel Medical.

Cantel Medical (NYSE:CMD) last issued its quarterly earnings results on Monday, September 23rd. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.02. The business had revenue of $239.48 million during the quarter, compared to analyst estimates of $238.60 million. Cantel Medical had a return on equity of 15.34% and a net margin of 5.99%.

Shares of Cantel Medical stock opened at $77.71 on Friday. The stock’s 50-day simple moving average is $72.83 and its 200-day simple moving average is $78.12. Cantel Medical has a 52 week low of $63.47 and a 52 week high of $93.87. The company has a market capitalization of $3.27 billion, a price-to-earnings ratio of 32.45 and a beta of 1.00. The company has a quick ratio of 1.41, a current ratio of 2.32 and a debt-to-equity ratio of 0.33.

Cantel Medical Company Profile

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Endoscopy segment offers automated endoscope reprocessing systems; infectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets, transport systems, and mobile medical carts; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services.

Read More: How is the discount rate different from the Federal Funds rate?

Get a free copy of the Zacks research report on Cantel Medical (CMD)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Cantel Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cantel Medical and related companies with MarketBeat.com's FREE daily email newsletter.